Search - tctmd.com

Displaying 41 - 60 of 61

Sort: Relevancy | Date

News Daily News

Breast Calcifications May Hold Important Clues for CV Risk Stratification

L.A. McKeown

February 22, 2019

News Conference News WCC 2018

WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai

Todd Neale

December 05, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Conference News SCAI 2018

Injured and Sleep Deprived: Are the Physical Tolls of Interventional Cardiology Too High?

L.A. McKeown

May 04, 2018

News Daily News

LPA Variants Linked With CHD Events in Statin-Treated Patients

Michael O'Riordan

May 03, 2018

News Daily News

FDA’s ‘Medical Device Safety Action Plan’ Focuses on Product Life Cycles and Preventing Cyberattacks

L.A. McKeown

April 20, 2018

News Daily News

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

Michael O'Riordan

January 30, 2018

News Daily News

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

Yael L. Maxwell

January 24, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

AAFP Says It Cannot Endorse New Hypertension Guideline

Todd Neale

December 18, 2017

News Conference News AHA 2017

Long-Awaited Hypertension Guidelines Released at AHA

Todd Neale

November 13, 2017

News Daily News

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

Michael O'Riordan

October 10, 2017

News Daily News

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

L.A. McKeown

July 14, 2017

News Daily News

Alirocumab to Remain On Market While Companies Clash Over Patents

Michael O'Riordan

February 09, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

News Daily News

A Step in the Wrong Direction: Weight-Loss Efforts Could Be Hampered by Addition of Wearable Device

Yael L. Maxwell

September 21, 2016

News Industry News

FDA strengthens warning on NSAID labels

July 10, 2015

News Industry News

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

June 19, 2015

Advertisement

Breast Calcifications May Hold Important Clues for CV Risk Stratification

WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Injured and Sleep Deprived: Are the Physical Tolls of Interventional Cardiology Too High?

LPA Variants Linked With CHD Events in Statin-Treated Patients

FDA’s ‘Medical Device Safety Action Plan’ Focuses on Product Life Cycles and Preventing Cyberattacks

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

Maze of Prior Authorization for PCSK9 Inhibitors Poses Challenge to Prescribers

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

AAFP Says It Cannot Endorse New Hypertension Guideline

Long-Awaited Hypertension Guidelines Released at AHA

Alirocumab Ban Reversed, New Trial Ordered in PCSK9 Patent Dispute

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

Alirocumab to Remain On Market While Companies Clash Over Patents

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

A Step in the Wrong Direction: Weight-Loss Efforts Could Be Hampered by Addition of Wearable Device

FDA strengthens warning on NSAID labels

New Cost Effectiveness Model Underlines Scope of Polypill Strategy to Prevent Recurring Cardiovascular Events and for More Efficient Use of Health Budgets

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content